Maximilian Diehn, MD, PhD, an assistant professor in the Department of Radiation Oncology, Stanford Medicine, discusses some of the next steps researchers are taking with liquid biopsies in the field of lung cancer.
Maximilian Diehn, MD, PhD
Advertisement
Articles by Maximilian Diehn, MD, PhD
Advertisement
Latest Updated Articles
Dr. Diehn on Next Steps With Liquid Biopsies in Lung CancerAugust 25th 2017
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Palbociclib Plus Trastuzumab, With/Without Pertuzumab, and ET as Maintenance in HR+, HER2+ Metastatic Breast Cancer
2
FDA Approves Sacituzumab Govitecan Monotherapy and In Combination With Pembrolizumab in Frontline TNBC
3
Perioperative Pembrolizumab/Enfortumab Vedotin Approved in Europe for Cisplatin-Ineligible MIBC
4
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
5